ASGCT 2026

CAMBRIDGE, Mass., May 12, 2026 Mirai Bio unveiled new preclinical data at the American Society of Gene and Cell...

NEW YORK, May 11, 2026 Myrtelle announced new clinical and regulatory updates for its investigational gene therapy candidate MYR-101...

DALLAS, May 11, 2026 Nanoscope Therapeutics announced multiple scientific presentations at the American Society of Gene and Cell Therapy...

BERKELEY, California, United States – May 8, 2026 Azalea Therapeutics announced groundbreaking late-breaking data at the upcoming American Society...

BOSTON, Mass., May 8, 2026 Ensoma announced the presentation of initial clinical safety data from the first participant dosed...

SOUTH SAN FRANCISCO, Calif., May 2026 Mission Bio announced new data demonstrating the power of its Targeted Single-Cell DNA+RNA...

Seattle, WA; Cambridge, MA; Tokyo, Japan – May 6, 2026 Aurion Biotech, Inc. announced that it will deliver an...

San Rafael, California, United States | May 2, 2026 BioMarin Pharmaceutical Inc. has presented new long-term clinical data for...

Alameda, California, United States | April 30, 2026 Scribe Therapeutics has announced significant advancements in its engineered CRISPR gene...

BOSTON, Massachusetts, May 2026 Kernal Biologics announced it will present new data on its mRNA 2.0 platform and T-cell-targeted...